Aquaviron

Testosterone (medication) consists of synthetic forms of the primary male sex hormone, administered to men with diagnosed hypogonadism or other conditions causing deficient endogenous testosterone production, such as primary or secondary testicular failure.[1] The U.S. Food and Drug Administration approves its use solely for replacement therapy in cases linked to specific medical etiologies, excluding routine treatment for age-related declines without accompanying pathology, due to insufficient evidence of net benefit and potential risks.[2] By elevating serum testosterone to normal physiological ranges, it addresses symptoms including diminished libido, erectile dysfunction, fatigue, reduced muscle mass, and depressed mood, with clinical trials demonstrating improvements in these domains for confirmed hypogonadal patients.[3]